BW
JAZZ icon

BIP Wealth’s Jazz Pharmaceuticals JAZZ Stock Holding History

BIP Wealth’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$810K Hold
4,283
– – 0.03% 228
2025
Q4 		$728K Hold
4,283
– – 0.03% 246
2025
Q3 		$564K Hold
4,283
– – 0.03% 175
2025
Q2 		$455K Hold
4,283
– – 0.03% 161
2025
Q1 		$532K Buy
+4,283
New +$559K 0.03% 145

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BIP Wealth's JAZZ Position: Q1 2026 in Review

BIP Wealth held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 4,283 shares worth $810K. The position accounts for 0.03% of the portfolio, ranked #228.

BIP Wealth first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • BIP Wealth held 4,283 shares of Jazz Pharmaceuticals worth $810K as of Q1 2026.
  • BIP Wealth left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up 0.03% of BIP Wealth's portfolio in Q1 2026, its #228 holding.
  • BIP Wealth first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on BIP Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.